IN2012DN02632A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02632A IN2012DN02632A IN2632DEN2012A IN2012DN02632A IN 2012DN02632 A IN2012DN02632 A IN 2012DN02632A IN 2632DEN2012 A IN2632DEN2012 A IN 2632DEN2012A IN 2012DN02632 A IN2012DN02632 A IN 2012DN02632A
- Authority
- IN
- India
- Prior art keywords
- hydroxyl
- hydrogen
- optionally substituted
- hydrocarbon group
- group optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009228406 | 2009-09-30 | ||
PCT/JP2010/066998 WO2011040496A1 (ja) | 2009-09-30 | 2010-09-29 | ヘパラナーゼ活性阻害剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN02632A true IN2012DN02632A (de) | 2015-09-04 |
Family
ID=43826308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2632DEN2012 IN2012DN02632A (de) | 2009-09-30 | 2010-09-29 |
Country Status (12)
Country | Link |
---|---|
US (2) | US8609075B2 (de) |
EP (1) | EP2484359B1 (de) |
JP (2) | JP5593323B2 (de) |
KR (1) | KR101431348B1 (de) |
CN (1) | CN102655863B (de) |
BR (1) | BR112012007090A2 (de) |
ES (1) | ES2687780T3 (de) |
HK (1) | HK1171390A1 (de) |
IN (1) | IN2012DN02632A (de) |
RU (1) | RU2503454C1 (de) |
TW (1) | TWI461221B (de) |
WO (1) | WO2011040496A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5685369B2 (ja) * | 2009-09-15 | 2015-03-18 | 株式会社 資生堂 | ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法 |
JP2013032332A (ja) * | 2011-07-01 | 2013-02-14 | Lintec Corp | 免疫賦活剤 |
JP5258993B1 (ja) * | 2012-03-29 | 2013-08-07 | 株式会社 資生堂 | ヘパラン硫酸産生促進剤 |
JP6321506B2 (ja) * | 2014-09-22 | 2018-05-09 | 株式会社 資生堂 | ヘパラナーゼ阻害剤による美白方法及び美白効果を有する物質の評価方法 |
US11564959B2 (en) * | 2016-10-21 | 2023-01-31 | Shiseido Company, Ltd. | Screening method for laminin 511 production promoting agent, basal epidermal layer stabilizing agent, and/or epidermal stem cells reduction inhibiting or proliferation promoting agent |
US11718609B2 (en) | 2016-12-13 | 2023-08-08 | Beta Therapeutics Pty Ltd | Heparanase inhibitors and use thereof |
US11787783B2 (en) | 2016-12-13 | 2023-10-17 | Beta Therapeutics Pty Ltd | Heparanase inhibitors and use thereof |
EP3381906A1 (de) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Verbindungen als heparanasehemmer |
EP3381898A1 (de) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Symmetrische tris-aryl-amide-derivate und ihre verwendung als anti-heparanase |
EP3381897A1 (de) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Derivate des dinatrium 2,2'-{carbonylbis[imino-3,1-phenylencarbonylimino(1-methyl-1h-pyrrol-4,2-diyl)carbonylimino]}dinaphthalen-1,5-disulfonat salzes und verwandte verbindungen als heparanase inhibitoren zur behandlung von krebs |
EP3381908A1 (de) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | 2-(4-(4-brom-methoxybenzamido)benzylamino)phenyl)benzazol-derivate und deren verwendung als anti-heparanase |
EP3381907A1 (de) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Symmetrische 2-aminophenyl-benzazolyl-5-acetat-verbindungen und deren verwendung als anti-hepanarase |
EP3388439A1 (de) | 2017-04-11 | 2018-10-17 | Leadiant Biosciences SA | Biotinkonjugiertes n-acetylglycolgeteiltes heparin |
EP3639821A4 (de) | 2017-06-13 | 2021-03-17 | National Cancer Center | Karzinogenese-inhibitor |
WO2020219753A1 (en) * | 2019-04-24 | 2020-10-29 | University Of Florida Research Foundation, Incorporated | Heparanase compounds and methods of use |
CN116615196A (zh) * | 2020-12-15 | 2023-08-18 | 株式会社资生堂 | 真皮再生促进剂 |
TW202237061A (zh) | 2020-12-15 | 2022-10-01 | 日商資生堂股份有限公司 | 表皮幹細胞增加促進劑 |
CN118201596A (zh) | 2021-12-02 | 2024-06-14 | 株式会社资生堂 | 化妆品 |
CN118201590A (zh) * | 2021-12-03 | 2024-06-14 | 株式会社资生堂 | 化妆品 |
WO2023106121A1 (ja) * | 2021-12-09 | 2023-06-15 | 株式会社 資生堂 | 水中油型乳化化粧料 |
CN118251204A (zh) * | 2021-12-09 | 2024-06-25 | 株式会社资生堂 | 化妆品 |
WO2023120180A1 (ja) * | 2021-12-20 | 2023-06-29 | 株式会社 資生堂 | 水中油型乳化化粧料 |
WO2023149225A1 (ja) * | 2022-02-03 | 2023-08-10 | 株式会社 資生堂 | 皮膚外用組成物 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1256235A (en) * | 1917-03-31 | 1918-02-12 | William F Jacobs | Work-supporting horse. |
US4049650A (en) | 1976-10-18 | 1977-09-20 | Morton-Norwich Products, Inc. | 1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones |
US4731453A (en) | 1985-04-03 | 1988-03-15 | Mitsui Toatsu Chemicals, Inc. | Process for producing 1, 3-dialkyl-2-imidazolidinone |
US4593038A (en) * | 1985-04-03 | 1986-06-03 | Burzynski Stanislaw R | Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation |
US4960771A (en) * | 1988-07-12 | 1990-10-02 | Rajadhyaksha Vithal J | Oxazolidinone penetration enhancing compounds |
US5011621A (en) | 1990-06-04 | 1991-04-30 | Arco Chemical Technology, Inc. | Paint stripper compositions containing N-methyl-2-pyrrolidone and renewable resources |
US5583256A (en) | 1994-07-07 | 1996-12-10 | Mitsui Toatsu Chemicals, Inc. | Process for producing 1,3-dialkyl-2-imidazolidinone |
US5536740A (en) * | 1995-06-01 | 1996-07-16 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester |
US5837224A (en) | 1996-01-19 | 1998-11-17 | The Regents Of The University Of Michigan | Method of inhibiting photoaging of skin |
JPH11335235A (ja) | 1998-05-22 | 1999-12-07 | Shiseido Co Ltd | 抗老化剤 |
GB9913415D0 (en) | 1999-06-10 | 1999-08-11 | Central Manchester Healthcare | Heparanase assay |
JP2001163794A (ja) | 1999-12-03 | 2001-06-19 | Shiseido Co Ltd | ヒアルロン酸産生促進剤および皮膚外用剤 |
TWI233361B (en) | 2001-04-13 | 2005-06-01 | Gen Hospital Corp | Methods of preventing UVB-induced skin damage |
US20030129259A1 (en) * | 2001-12-28 | 2003-07-10 | Avon Products, Inc. | Topical lightening compostitions and methods of use |
ES2243606T3 (es) * | 2002-02-15 | 2005-12-01 | Goldschmidt Gmbh | Utilizacion de creatinina y/o de derivados de creatinina para el aclaramiento de la piel y el alivio de trastornos de pigmentacion. |
EP1559429A4 (de) | 2002-06-25 | 2009-09-09 | Shiseido Co Ltd | Mittel gegen alterung |
JP2007505938A (ja) * | 2003-09-23 | 2007-03-15 | ノバルティス アクチエンゲゼルシャフト | Vegf受容体阻害剤と化学療法剤の組み合わせ |
EP2065383A1 (de) * | 2003-11-19 | 2009-06-03 | Signal Pharmaceuticals, Inc. | Indazolverbindungen und Verwendungsverfahren davon als Proteinkinasehemmer |
FR2873377B1 (fr) * | 2004-07-23 | 2006-10-13 | Sanofi Synthelabo | Derives d'azasucre, inhibiteurs d'heparanases, leur procede de preparation, les compositions en contenant et leur utilisation |
US7238260B2 (en) | 2004-10-26 | 2007-07-03 | Lyondell Chemical Technology, L.P. | Purification of N-(2-hydroxyethyl)-2-pyrrolidone |
JP2006303185A (ja) | 2005-04-20 | 2006-11-02 | Matsushita Electric Ind Co Ltd | 半導体装置及びその製造方法 |
JP2007277149A (ja) | 2006-04-06 | 2007-10-25 | Kao Corp | インボルクリン発現促進剤 |
US8097581B2 (en) * | 2007-05-10 | 2012-01-17 | Grant Industries Inc. | Anti-wrinkle cosmetic composition |
CN101311188B (zh) * | 2007-05-21 | 2010-12-29 | 中国人民解放军军事医学科学院生物工程研究所 | 人乙酰肝素酶的小分子多肽抑制剂 |
JP5105962B2 (ja) * | 2007-06-08 | 2012-12-26 | 株式会社 資生堂 | コーニファイドエンベロープ形成・成熟化促進剤 |
JP2008303187A (ja) * | 2007-06-08 | 2008-12-18 | Shiseido Co Ltd | コーニファイドエンベロープ形成・成熟化促進剤 |
JP5179096B2 (ja) * | 2007-06-08 | 2013-04-10 | 株式会社 資生堂 | コーニファイドエンベロープ形成・成熟化促進剤 |
WO2009122540A1 (ja) * | 2008-03-31 | 2009-10-08 | 株式会社資生堂 | しわを防止または改善するための経口、注射、皮膚外用剤および美容方法 |
RU2537243C2 (ru) * | 2008-03-31 | 2014-12-27 | Сисейдо Компани, Лтд. | Пероральный препарат, препарат для инъекции, кожный препарат для наружного применения и косметический способ предупреждения появления или разглаживания морщин |
FR2931064B1 (fr) * | 2008-05-14 | 2010-08-13 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane |
-
2010
- 2010-09-29 IN IN2632DEN2012 patent/IN2012DN02632A/en unknown
- 2010-09-29 US US13/261,244 patent/US8609075B2/en active Active
- 2010-09-29 ES ES10820611.1T patent/ES2687780T3/es active Active
- 2010-09-29 WO PCT/JP2010/066998 patent/WO2011040496A1/ja active Application Filing
- 2010-09-29 EP EP10820611.1A patent/EP2484359B1/de active Active
- 2010-09-29 RU RU2012117797/15A patent/RU2503454C1/ru not_active IP Right Cessation
- 2010-09-29 CN CN2010800438641A patent/CN102655863B/zh active Active
- 2010-09-29 KR KR1020127004685A patent/KR101431348B1/ko active IP Right Grant
- 2010-09-29 JP JP2011534288A patent/JP5593323B2/ja active Active
- 2010-09-29 BR BR112012007090-8A patent/BR112012007090A2/pt not_active Application Discontinuation
- 2010-09-30 TW TW099133410A patent/TWI461221B/zh active
-
2012
- 2012-11-29 HK HK12112298.0A patent/HK1171390A1/xx not_active IP Right Cessation
-
2013
- 2013-11-18 US US14/082,440 patent/US8901160B2/en active Active
-
2014
- 2014-02-10 JP JP2014023264A patent/JP2014111640A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2484359A4 (de) | 2015-07-08 |
CN102655863B (zh) | 2013-11-20 |
EP2484359A1 (de) | 2012-08-08 |
RU2012117797A (ru) | 2013-11-10 |
TWI461221B (zh) | 2014-11-21 |
EP2484359B1 (de) | 2018-07-25 |
CN102655863A (zh) | 2012-09-05 |
US20140080878A1 (en) | 2014-03-20 |
KR20120060205A (ko) | 2012-06-11 |
WO2011040496A1 (ja) | 2011-04-07 |
US8609075B2 (en) | 2013-12-17 |
BR112012007090A2 (pt) | 2018-06-05 |
US8901160B2 (en) | 2014-12-02 |
AU2010301641A1 (en) | 2012-03-22 |
JPWO2011040496A1 (ja) | 2013-02-28 |
KR101431348B1 (ko) | 2014-08-19 |
ES2687780T3 (es) | 2018-10-29 |
TW201117832A (en) | 2011-06-01 |
RU2503454C1 (ru) | 2014-01-10 |
JP5593323B2 (ja) | 2014-09-24 |
HK1171390A1 (en) | 2013-03-28 |
US20120183481A1 (en) | 2012-07-19 |
JP2014111640A (ja) | 2014-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN02632A (de) | ||
MX338707B (es) | Compuestos heterociclicos activadores de proteina cinasa activada por 5'-amp (ampk) y metodos para emplearlos. | |
MX2016007661A (es) | Derivado de sulfonamida o sales de adicion de acido farmaceuticamente aceptables del mismo. | |
PH12015502514A1 (en) | An amorphous and crystalline form of genz 112638 hemitartrat as inhibitor of glucosylceramide synthase | |
MY160359A (en) | Low-molecular polysulfated hyaluronic acid derivative and medicine containing same | |
UA108510C2 (en) | Cyclopropane compound | |
MY156669A (en) | Pesticidal composition and its use | |
GEP20156309B (en) | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 | |
IN2012DN01350A (de) | ||
MY155658A (en) | A-isopropylphenyl glucitol compounds as sglti inhibitors | |
MX2013002233A (es) | Agente de control de plagas. | |
NO20090856L (no) | STAT3/5 activeringsinhibitor | |
MY161094A (en) | Anti-tumor effect potentiator | |
GB2515909A (en) | Polymer | |
NO20091746L (no) | Nytt difenylazetidinon substituert med piperazin-1-sulfonsyre med forbedrede farmakologiske egenskaper | |
RS53900B1 (en) | CRYSTAL FORMS OF HYDROCHLORIDE SALTS (4A-R, 9A-S) -1- (1H-BENZOIMIDAZOL-5-CARBONYL) -2,3,4,4A, 9,9A-HEXAHIDRO-1H-INDENO [2,1-B] PIRIDIN-6-CARBONITRILA AND THEIR USE AS A HSD INHIBITOR 1 | |
MX2013012982A (es) | Metodo para promover el crecimiento de plantas. | |
IN2012DN00694A (de) | ||
MY194452A (en) | 1,4-Butanediol-Containing Composition | |
WO2012024397A3 (en) | 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | |
BR112014015430A2 (pt) | formulação oftálmica | |
MY179437A (en) | Preventing or ameliorating agent for pigmentation | |
GEP20156295B (en) | 1,4-oxazepane derivatives | |
TH124389B (th) | สารยับยั้งเฮปาราเนส แอคตีวิตี้ | |
MX355654B (es) | Derivado de paroxetina. |